Cell, volume 181, issue 5, pages 1004-1015.e15

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

Daniel Wrapp 1
Dorien De Vlieger 2
Gretel M Torres 4
Nianshuang Wang 1
Wander Van Breedam 2
K. Roose 2
Loes Van Schie 2
Markus Hoffmann 5
B. Graham 3
Nico Callewaert 2
B. Schepens 2
Jason S. McLellan 1
Publication typeJournal Article
Publication date2020-05-05
Journal: Cell
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor64.5
ISSN00928674, 10974172
General Biochemistry, Genetics and Molecular Biology
Abstract

Summary

Coronaviruses make use of a large envelope protein called spike (S) to engage host cell receptors and catalyze membrane fusion. Because of the vital role that these S proteins play, they represent a vulnerable target for the development of therapeutics. Here, we describe the isolation of single-domain antibodies (VHHs) from a llama immunized with prefusion-stabilized coronavirus spikes. These VHHs neutralize MERS-CoV or SARS-CoV-1 S pseudotyped viruses, respectively. Crystal structures of these VHHs bound to their respective viral targets reveal two distinct epitopes, but both VHHs interfere with receptor binding. We also show cross-reactivity between the SARS-CoV-1 S-directed VHH and SARS-CoV-2 S and demonstrate that this cross-reactive VHH neutralizes SARS-CoV-2 S pseudotyped viruses as a bivalent human IgG Fc-fusion. These data provide a molecular basis for the neutralization of pathogenic betacoronaviruses by VHHs and suggest that these molecules may serve as useful therapeutics during coronavirus outbreaks.

Top-30

Citations by journals

2
4
6
8
10
12
14
16
Scientific Reports
16 publications, 3.46%
Nature Communications
12 publications, 2.59%
Proceedings of the National Academy of Sciences of the United States of America
11 publications, 2.38%
Frontiers in Immunology
9 publications, 1.94%
Cell Reports
8 publications, 1.73%
Viruses
6 publications, 1.3%
PLoS Pathogens
6 publications, 1.3%
Cell
6 publications, 1.3%
Science
5 publications, 1.08%
International Journal of Molecular Sciences
5 publications, 1.08%
iScience
5 publications, 1.08%
Cells
4 publications, 0.86%
Signal Transduction and Targeted Therapy
4 publications, 0.86%
Communications Biology
4 publications, 0.86%
Journal of Biological Chemistry
4 publications, 0.86%
International Journal of Biological Macromolecules
4 publications, 0.86%
Advanced Science
4 publications, 0.86%
mAbs
4 publications, 0.86%
Science advances
4 publications, 0.86%
Journal of Medical Virology
3 publications, 0.65%
Frontiers in Molecular Biosciences
3 publications, 0.65%
International Immunopharmacology
3 publications, 0.65%
Computational and Structural Biotechnology Journal
3 publications, 0.65%
Immunity
3 publications, 0.65%
Biochemical and Biophysical Research Communications
3 publications, 0.65%
Advances in Immunology
2 publications, 0.43%
International Journal of Nanomedicine
2 publications, 0.43%
Biosensors
2 publications, 0.43%
Journal of Nanobiotechnology
2 publications, 0.43%
2
4
6
8
10
12
14
16

Citations by publishers

10
20
30
40
50
60
70
80
90
100
Elsevier
97 publications, 20.95%
Cold Spring Harbor Laboratory
89 publications, 19.22%
Springer Nature
68 publications, 14.69%
Wiley
35 publications, 7.56%
Multidisciplinary Digital Publishing Institute (MDPI)
29 publications, 6.26%
American Chemical Society (ACS)
18 publications, 3.89%
Frontiers Media S.A.
17 publications, 3.67%
American Association for the Advancement of Science (AAAS)
12 publications, 2.59%
Proceedings of the National Academy of Sciences (PNAS)
11 publications, 2.38%
Public Library of Science (PLoS)
9 publications, 1.94%
American Society for Microbiology
9 publications, 1.94%
Taylor & Francis
8 publications, 1.73%
Oxford University Press
6 publications, 1.3%
American Society for Biochemistry and Molecular Biology
4 publications, 0.86%
Royal Society of Chemistry (RSC)
4 publications, 0.86%
Bentham Science
4 publications, 0.86%
EMBO press
3 publications, 0.65%
Annual Reviews
3 publications, 0.65%
Mary Ann Liebert
2 publications, 0.43%
Dove Medical Press
2 publications, 0.43%
SAGE
2 publications, 0.43%
KeAi Communications Co.
2 publications, 0.43%
The Royal Society
2 publications, 0.43%
The American Association of Immunologists
1 publication, 0.22%
American Society for Clinical Investigation
1 publication, 0.22%
Microbiology Society
1 publication, 0.22%
NEJM Group
1 publication, 0.22%
Portland Press
1 publication, 0.22%
Baishideng Publishing Group
1 publication, 0.22%
10
20
30
40
50
60
70
80
90
100
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Wrapp D. et al. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies // Cell. 2020. Vol. 181. No. 5. p. 1004-1015.e15.
GOST all authors (up to 50) Copy
Wrapp D., De Vlieger D., Corbett K. S., Torres G. M., Wang N., Van Breedam W., Roose K., Van Schie L., Hoffmann M., Pöhlmann S., Graham B., Callewaert N., Schepens B., Saelens X., McLellan J. S. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies // Cell. 2020. Vol. 181. No. 5. p. 1004-1015.e15.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.cell.2020.04.031
UR - https://doi.org/10.1016/j.cell.2020.04.031
TI - Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
T2 - Cell
AU - Wrapp, Daniel
AU - De Vlieger, Dorien
AU - Corbett, Kizzmekia S.
AU - Torres, Gretel M
AU - Wang, Nianshuang
AU - Van Breedam, Wander
AU - Roose, K.
AU - Van Schie, Loes
AU - Hoffmann, Markus
AU - Pöhlmann, Stefan
AU - Graham, B.
AU - Callewaert, Nico
AU - Schepens, B.
AU - Saelens, Xavier
AU - McLellan, Jason S.
PY - 2020
DA - 2020/05/05 00:00:00
PB - Elsevier
SP - 1004-1015.e15
IS - 5
VL - 181
PMID - 32375025
SN - 0092-8674
SN - 1097-4172
ER -
BibTex |
Cite this
BibTex Copy
@article{2020_Wrapp,
author = {Daniel Wrapp and Dorien De Vlieger and Kizzmekia S. Corbett and Gretel M Torres and Nianshuang Wang and Wander Van Breedam and K. Roose and Loes Van Schie and Markus Hoffmann and Stefan Pöhlmann and B. Graham and Nico Callewaert and B. Schepens and Xavier Saelens and Jason S. McLellan},
title = {Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies},
journal = {Cell},
year = {2020},
volume = {181},
publisher = {Elsevier},
month = {may},
url = {https://doi.org/10.1016/j.cell.2020.04.031},
number = {5},
pages = {1004--1015.e15},
doi = {10.1016/j.cell.2020.04.031}
}
MLA
Cite this
MLA Copy
Wrapp, Daniel, et al. “Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.” Cell, vol. 181, no. 5, May. 2020, pp. 1004-1015.e15. https://doi.org/10.1016/j.cell.2020.04.031.
Found error?